Clapper, E.; Wang, S.; Raninga, P.V.; Di Trapani, G.; Tonissen, K.F.
Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment. Antioxidants 2020, 9, 207.
https://doi.org/10.3390/antiox9030207
AMA Style
Clapper E, Wang S, Raninga PV, Di Trapani G, Tonissen KF.
Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment. Antioxidants. 2020; 9(3):207.
https://doi.org/10.3390/antiox9030207
Chicago/Turabian Style
Clapper, Erin, Sicong Wang, Prahlad V. Raninga, Giovanna Di Trapani, and Kathryn F. Tonissen.
2020. "Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment" Antioxidants 9, no. 3: 207.
https://doi.org/10.3390/antiox9030207
APA Style
Clapper, E., Wang, S., Raninga, P. V., Di Trapani, G., & Tonissen, K. F.
(2020). Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment. Antioxidants, 9(3), 207.
https://doi.org/10.3390/antiox9030207